Research Topics
| J G WebbSummaryAffiliation: University of British Columbia Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosisJohn G Webb
Division of Cardiology, St Paul s Hospital and the Centre for Health Evaluation and Outcome Sciences, University of British Columbia, Vancouver, British Columbia, Canada
Circulation 116:755-63. 2007..Percutaneous aortic valve replacement represents an endovascular alternative to conventional open heart surgery without the need for sternotomy, aortotomy, or cardiopulmonary bypass...
Transcatheter aortic valve implantation: impact on clinical and valve-related outcomesJohn G Webb
St Paul s Hospital, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada
Circulation 119:3009-16. 2009..Transcatheter aortic valve implantation is an alternative to open heart surgery in patients with aortic stenosis. However, long-term data on a programmatic approach to aortic valve implantation remain sparse...
Percutaneous stent-mounted valve for treatment of aortic or pulmonary valve diseaseJohn G Webb
Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Catheter Cardiovasc Interv 63:89-93. 2004..Further evolution of this technology will involve lower-profile devices with design features that facilitate vascular delivery, visualization, positioning, deployment, and valvular function...
A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effectJohn G Webb
Division of Cardiology, Pharmacy Department, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Am Heart J 148:422-9. 2004..The objective of this study was to evaluate, in a blinded, randomized, placebo-controlled fashion, whether intravenous NAC reduced CIN in the setting of cardiac catheterization in patients with preexisting renal insufficiency...
Proximal protection during saphenous vein graft angioplasty: the Kerberos embolic protection systemJohn G Webb
Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, Canada
Catheter Cardiovasc Interv 64:383-6. 2005..Although such systems are often effective, distal protection does have limitations. We report a novel proximal embolic protection and rinsing system intended to overcome some of these limitations...
Percutaneous closure of an aortic prosthetic paravalvular leak with an Amplatzer duct occluderJohn G Webb
Department of Cardiology, St Paul s Hospital, University of British Columbia, 1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada
Catheter Cardiovasc Interv 65:69-72. 2005..We describe in a patient with severe aortic prosthetic paravalvular leak the use of an Amplatzer duct occluder device resulting in effective closure and symptomatic improvement...
Percutaneous suture edge-to-edge repair of the mitral valveJohn G Webb
St Paul s Hospital, University of British Columbia, Vancouver, Canada
EuroIntervention 5:86-9. 2009....
Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinusJohn G Webb
St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Circulation 113:851-5. 2006..We evaluated the safety and feasibility of a transvenous catheter-delivered implantable device to provide a percutaneous alternative to surgical mitral annuloplasty...
Percutaneous aortic valve implantation retrograde from the femoral arteryJohn G Webb
Division of Cardiology, St Paul s Hospital, Vancouver, British Columbia, Canada
Circulation 113:842-50. 2006..Retrograde prosthetic aortic valve implantation via the femoral artery has potential advantages. Percutaneous prosthetic aortic valve implantation via the femoral arterial approach is described and the initial experience reported...
Percutaneous aortic valve replacement will become a common treatment for aortic valve diseaseJohn G Webb
Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, Canada
JACC Cardiovasc Interv 1:122-6. 2008..Caution is prudent, however, in the future a more mature procedure might represent a viable alternative for a much broader range of patients...
A new transcatheter aortic valve and percutaneous valve delivery systemJohn G Webb
Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
J Am Coll Cardiol 53:1855-8. 2009..We describe procedural and clinical outcomes in a high-risk cohort undergoing transcatheter aortic valve replacement with early next-generation transcatheter valve and delivery systems...
Percutaneous transarterial aortic valve implantation: what do we know?John Webb
St Paul s Hospital, University of British Columbia, 1081 Burrard Street, Vancouver, BC, Canada
Eur Heart J 32:140-7. 2011..Nevertheless considerable work needs to be done before the indications for TAVI are expanded into lower risk groups. We review what is currently known about percutaneous transarterial implantation of the aortic valve...
Rapid pacing to facilitate transcatheter prosthetic heart valve implantationJohn G Webb
Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, BC, Canada
Catheter Cardiovasc Interv 68:199-204. 2006..We describe the technique of, and our experience with, rapid ventricular burst pacing to facilitate transcatheter heart valve implantation...
Percutaneous aortic valve replacementJohn G Webb
St Paul s Hospital, 1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada
Curr Cardiol Rep 10:104-9. 2008..Procedural success rates and clinical outcomes continue to improve. Current studies suggest that morbidity and mortality are competitive in comparison to conventional surgery in selected high-risk patients...
Transcatheter percutaneous and transapical aortic valve replacementJohn G Webb
Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, BC, USA
Semin Thorac Cardiovasc Surg 19:304-10. 2007..Uncertainty remains about outcomes, implications, durability, and the appropriate role for this new therapy. It appears likely that transcatheter valve implantation will become a more widely available and accepted therapeutic option...
Percutaneous coronary intervention for cardiogenic shock in the SHOCK trialJohn G Webb
St Paul s Hospital, Vancouver, Canada
J Am Coll Cardiol 42:1380-6. 2003..We examined the clinical, angiographic, and procedural characteristics determining survival after percutaneous coronary intervention (PCI) for cardiogenic shock...
Incidence, correlates, and outcome of cardiac arrest associated with percutaneous coronary interventionJohn G Webb
Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver; Canada
Am J Cardiol 90:1252-4. 2002
Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial RegistryJ G Webb
St Paul s Hospital, Vancouver, British Columbia, Canada
Am Heart J 141:964-70. 2001..The SHOCK Registry prospectively enrolled patients with cardiogenic shock complicating acute myocardial infarction in 36 multinational centers...
Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?J G Webb
St Paul s Hospital, Vancouver, British Columbia, Canada
J Am Coll Cardiol 36:1084-90. 2000..We sought to examine the implications of the timing of onset of cardiogenic shock (CS) after acute myocardial infarction (MI)...
Transient obstruction of the mitral valve by a massive thrombus complicating percutaneous valvuloplastyA W Chan
Interventional Cardiology, St PaulOs Hospital, 502Eth 1160 Burrard Street, Vancouver, British Columbia, V6Z 2E8, Canada
J Invasive Cardiol 12:324-6. 2000..Circulatory arrest ensued. The thrombus was disrupted during cardiopulmonary resuscitation. Thrombolysis was administered and the patient recovered uneventfully...
Facilitation of stent retention and retrieval with an emboli containment deviceJ G Webb
Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, Canada
Catheter Cardiovasc Interv 50:215-7. 2000..We describe how, when used for the prevention of distal embolization of atheromatous or thrombotic particles, this device may facilitate retention and retrieval of undeployed stents...
Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK?C R Thompson
Division of Cardiology, St Paul s Hospital, Vancouver, British Columbia, Canada
J Am Coll Cardiol 36:1104-9. 2000..Our objective was to define the outcomes of patients with cardiogenic shock (CS) due to severe mitral regurgitation (MR) complicating acute myocardial infarction (AMI)...
Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?V Menon
Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University, New York, New York 10025, USA
J Am Coll Cardiol 36:1110-6. 2000..We wished to assess the profile and outcomes of patients with ventricular septal rupture (VSR) in the setting of cardiogenic shock (CS) complicating acute myocardial infarction (MI)...
Technical considerations to avoid pitfalls during transapical aortic valve implantationDaniel R Wong
Division of Cardiac Surgery, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
J Thorac Cardiovasc Surg 140:196-202. 2010..Transapical aortic valve implantation is a recent therapeutic advance for aortic valvular disease. We sought to identify complications--and the relevant technical and management considerations--from our learning curve with this procedure...
The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?V Menon
Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University, New York, New York 10025, USA
J Am Coll Cardiol 36:1071-6. 2000..We sought to evaluate the frequency of pulmonary congestion and associated clinical and hemodynamic findings in patients with suspected cardiogenic shock (CS)...
Prevention and management of transcatheter balloon-expandable aortic valve malpositionAbdullah M Al Ali
Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, Canada
Catheter Cardiovasc Interv 72:573-8. 2008..To this end, we examined our experience during the developmental phases of transcatheter AVR and describe the causes and management of prosthetic valve malposition...
Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complicationsJean Bernard Masson
Division of Cardiology and Cardiac Surgery, St Paul s Hospital, University of British Columbia, Vancouver, Canada
JACC Cardiovasc Interv 2:811-20. 2009..Ultimately, improved understanding of the potential complications associated with TAVI might help improve outcomes and allow wider application of this therapy...
Interventional management of cardiogenic shockJ G Webb
St Paul s Hospital, University of British Columbia, Vancouver
Can J Cardiol 14:233-44. 1998..Angiography can be performed at relatively low risk in shock patients. A window of opportunity is often available where revascularization may be of benefit...
Retrieval and analysis of particulate debris after saphenous vein graft interventionJ G Webb
St Paul s Hospital, University of British Columbia, Vancouver, Canada
J Am Coll Cardiol 34:468-75. 1999..This study was designed to evaluate the composition and quantity of particulate debris resulting from vein graft intervention...
Role of multislice computed tomography in transcatheter aortic valve replacementDavid A Wood
Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Am J Cardiol 103:1295-301. 2009..Neither eccentricity nor calcific deposits appeared to contribute significantly to severity of paravalvular regurgitation after TAVR...
Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valveRobert H Boone
St Paul s Hospital, University of British Columbia, Vancouver, Canada
Catheter Cardiovasc Interv 75:286-94. 2010..Transcatheter pulmonary valve implantation improves conduit hemodynamics through a minimally invasive approach. We present data for 7 patients treated with the Edwards SAPIEN transcatheter heart valve (THV)...
Impact of coronary artery disease on outcomes after transcatheter aortic valve implantationJean Bernard Masson
St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Catheter Cardiovasc Interv 76:165-73. 2010..Implications of CAD and preprocedural revascularization in the setting of transcatheter aortic valve implantation (TAVI) are not known...
Correlation of remote ST segment depression and coronary anatomy during acute coronary occlusionA W Chan
Division of Cardiology, St Paul s Hospital, Vancouver, Canada
Can J Cardiol 17:282-90. 2001..The appearance of remote ST segment depression (RSTD) on an electrocardiogram (ECG) is associated with more extensive infarction and a worse clinical outcome than when RSTD is absent...
Percutaneous mitral annuloplastyJean Bernard Masson
St Paul s Hospital, University of British Columbia, Vancouver, Canada
Coron Artery Dis 20:183-8. 2009..We review current experimental percutaneous approaches to mitral annuloplasty...
Transcatheter closure of paravalvular defects using a purpose-specific occluderFabian Nietlispach
St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
JACC Cardiovasc Interv 3:759-65. 2010..This study sought to describe a method of paravalvular leak closure using a purpose-specific occlusion device...
Transcatheter valve-in-valve implantation for failed bioprosthetic heart valvesJohn G Webb
St Paul s Hospital, 1081 Burrard St, Vancouver, BC, Canada
Circulation 121:1848-57. 2010..Transcatheter heart valve implantation within a failed bioprosthesis, a "valve-in-valve" procedure, may offer a less invasive alternative...
Suture closure of femoral arterial puncture sites after coronary angioplasty followed by same-day dischargeR G Carere
Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver
Am Heart J 139:52-8. 2000..The purpose of this study was to determine whether immediate suture closure of 8F femoral arterial puncture sites can facilitate same-day discharge after coronary angioplasty...
Unprotected left main coronary artery stenting for cardiac allograft vasculopathyA W Chan
Division of Cardiology, St. Paul's Hospital, Vancouver, British Columbia, Canada
J Heart Lung Transplant 20:776-80. 2001..We present our initial experience with stenting of the left main coronary artery in the setting of allograft vasculopathy...
Atrioventricular block after transcatheter balloon expandable aortic valve implantationAjay Sinhal
Heart Centre, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
JACC Cardiovasc Interv 1:305-9. 2008..Transcatheter aortic valve replacement (AVR) is a promising approach to aortic valve disease. The implications of this new therapy are not entirely known. We describe the potential for the development of new atrioventricular (AV) block...
Abbreviated infusion of eptifibatide after successful coronary intervention The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) randomized trialAnthony Y Fung
Vancouver General Hospital, British Columbia, Canada
J Am Coll Cardiol 53:837-45. 2009..The purpose of this study was to assess whether the early discontinuation of eptifibatide infusion in nonemergent percutaneous coronary intervention (PCI) is associated with a higher frequency of periprocedural ischemic myonecrosis...
Current balloon-expandable transcatheter heart valve and delivery systemsFabian Nietlispach
Department of Cardiology, St Paul s Hospital, British Columbia, Canada
Catheter Cardiovasc Interv 75:295-300. 2010..Transcatheter valve and valve delivery systems are undergoing rapid evolution. We describe the current generation balloon-expandable valve and delivery systems...
Percutaneous coronary intervention and 30-day mortality: the British Columbia PCI risk scoreJaap N Hamburger
Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada
Catheter Cardiovasc Interv 74:377-85. 2009..To construct a calculator to assess the risk of 30-day mortality following PCI...
Transapical transcatheter aortic valve implantation in humans: initial clinical experienceSamuel V Lichtenstein
Divisions of Cardiology and Cardiac Surgery, St Paul's Hospital, University of British Columbia, Vancouver, Canada
Circulation 114:591-6. 2006..CONCLUSIONS: This initial experience suggests that transapical aortic valve implantation without cardiopulmonary bypass is feasible in selected patients with aortic stenosis...
Percutaneous aortic valve implantation: a case reportMann Chandavimol
St. Paul's Hospital, Vancouver, Canada
Can J Cardiol 22:1159-61. 2006..Currently, this procedure is an option only for symptomatic patients who are not appropriate candidates for surgical valve replacement...
CT of the ilio-femoral arteries using direct aortic contrast injection: proof of feasibility in patients screened towards percutaneous aortic valve replacementFabian Nietlispach
Division of Interventional Cardiology, Department of Cardiology, St Paul s Hospital, 1081 Burrard Street, Vancouver, British Columbia, Canada
Swiss Med Wkly 139:458-62. 2009..However, MSCT involves an additional contrast dye burden in patients often suffering from renal failure. In this study, the feasibility of direct-aortic-contrast-injection for MSCT was investigated, aiming to reduce total contrast load...
Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohortR Gurvitch
St Paul s Hospital, 1081 Burrard St, Vancouver, British Columbia, Canada V6Z 1Y6
Circulation 122:1319-27. 2010..Although short- and medium-term outcomes after transcatheter aortic valve implantation are encouraging, long-term data on valve function and clinical outcomes are limited...
Transapical transcatheter aortic valve implantation: follow-up to 3 yearsJian Ye
Division of Cardiac Surgery, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
J Thorac Cardiovasc Surg 139:1107-13, 1113.e1. 2010..We now report clinical and echocardiographic outcomes of transapical aortic valve implantation in 71 patients...
Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patientsJian Ye
Division of Cardiac Surgery, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
J Thorac Cardiovasc Surg 137:167-73. 2009..This is, to date, the longest follow-up of patients undergoing transapical aortic valve implantation...
Transapical transcatheter mitral valve-in-valve implantation in a humanAnson Cheung
Division of Cardiac Surgery, St Paul s Hospital, University of British Columbia, Vancouver, Canada
Ann Thorac Surg 87:e18-20. 2009..The transcatheter valve functioned properly postoperatively; however, the patient died of multiple organ dysfunction...
The evolving role of MDCT in transcatheter aortic valve replacement: a radiologists' perspectiveJonathon Leipsic
Department of Radiology, St Paul s Hospital Medical Imaging, University of British Columbia, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada
AJR Am J Roentgenol 193:W214-9. 2009..CONCLUSION: TAVR is developing into an effective and reproducible therapy for aortic valve stenosis. We describe the important role of MDCT in planning and performing TAVR in a large transcatheter valve program...
Role of echocardiography in percutaneous aortic valve implantationRobert R Moss
Division of Cardiology, St Paul s Hospital, Vancouver, British Columbia, Canada
JACC Cardiovasc Imaging 1:15-24. 2008..This study was designed to investigate the usefulness and limitations of echocardiography in optimizing the outcome of percutaneous aortic valve implantation...
Guideline adjudicated fibrinolytic failure: incidence, findings, and management in a contemporary clinical trialChristopher E Buller
University of British Columbia, Vancouver General Hospital, Vancouver, British Columbia, Canada
Am Heart J 155:121-7. 2008..We sought to describe the frequency of fibrinolytic failure (rescue eligibility) as well as the patient characteristics associated with rescue eligibility, rescue referral, and PCI...
Transcatheter valve-in-valve aortic valve implantation: 16-month follow-upJian Ye
Division of Cardiac Surgery, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Ann Thorac Surg 88:1322-4. 2009..Transcatheter transapical valve-in-valve aortic valve implantation is feasible and could be a viable approach for selected patients...
Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patientsJian Ye
Divisions of Cardiac Surgery and Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, Canada
Eur J Cardiothorac Surg 31:16-21. 2007..We now report 6-month follow-up in our initial seven patients...
N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?Stephen J Shalansky
Pharmacy Department, St Paul s Hospital, and Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada
Pharmacotherapy 25:1095-103. 2005....
Percutaneous closure of prosthetic paravalvular leaks: case series and reviewGordon E Pate
Division of Cardiology, St. Paul's Hospital and the University of British Columbia, Vancouver, British Columbia, Canada
Catheter Cardiovasc Interv 68:528-33. 2006..CONCLUSIONS: Percutaneous closure of PVLs is time-consuming but feasible in selected patients, with a reasonable degree of technical and clinical success. A second procedure may be necessary and a variety of complications can occur...
N-acetylcysteine reduces urinary albumin excretion following contrast administration: evidence of biological effectAdeera Levin
Division of Nephrology, Room 6010, Providence Health Care Saint Paul s Hospital, University of British Columbia, 1081 Burrard Street, Vancouver V6Z 1Y6, BC, Canada
Nephrol Dial Transplant 22:2520-4. 2007....
Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatmentChristopher E Buller
University of British Columbia, Vancouver
Can J Cardiol 22:511-5. 2006..Few data exist describing the use of subcutaneous or intravenous enoxaparin as an anticoagulant in the highly thrombotic setting of primary percutaneous coronary intervention (PCI) for STEMI...
Venture wire control catheterSamuel J McClure
Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Catheter Cardiovasc Interv 66:346-50. 2005..There were no device-related complications. Percutaneous coronary intervention was successful in all patients. Our initial experience with the Venture wire control catheter has been favorable...
An unusual complication of coil embolization of a large coronary-pulmonary fistulaGordon E Pate
Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada
J Invasive Cardiol 15:717-8. 2003..This case highlights an unusual complication of fistula embolization and emphasizes the need for caution when occluding vessels which may supply the sinus node...
Techniques for percutaneous closure of prosthetic paravalvular leaksGordon E Pate
Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Catheter Cardiovasc Interv 67:158-66. 2006..Reports are few; success variable and techniques vary widely. We review the current considerations and techniques of percutaneous transcatheter closure of paravalvular leaks...
Procedural efficacy and complications of X-Sizer thrombectomy in de novo and stented lesionsGordon E Pate
Division of Cardiology, St. Paul's Hospital and Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Catheter Cardiovasc Interv 63:177-82; discussion 183. 2004..The X-Sizer thrombectomy device improves TIMI flow but does not always prevent distal embolization. Care is needed when treating in-stent thrombosis...
Endovascular balloon occlusion for catheter-induced large artery perforation in the catheterization laboratoryJean Bernard Masson
Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Catheter Cardiovasc Interv 73:514-8. 2009..Endovascular occlusion may provide rapid control of hemorrhage and facilitate definitive therapy; yet, occlusion balloons are not commonly utilized in the cardiac catheterization laboratory...
Water for contrast-induced nephropathy? A thirst for knowledgeGordon E Pate
Division of Cardiology, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
J Invasive Cardiol 15:703-5. 2003
Repeated Günther Tulip inferior vena cava filter repositioning to prolong implantation timeKiang-Hiong Tay
Department of Radiology, University of British Columbia Hospitals, Campus Site, 2211 Wesbrook Mall, Vancouver, V6T 2B5 British Columbia, Canada
J Vasc Interv Radiol 13:509-12. 2002..In this way, the implantation time of the filter was extended beyond the recommended period of 10 days. The filter was successfully retrieved 19 days later during percutaneous closure of the PFO...
Transapical aortic valve implantation in humansJian Ye
Division of Cardiac Surgery, St Paul's Hospital, University of British Columbia, Vancouver, BC, Canada
J Thorac Cardiovasc Surg 131:1194-6. 2006
Percutaneous closure of a para-anastomotic abdominal aortic graft leakAbdulmajeed Alzubaidi
Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada
Catheter Cardiovasc Interv 68:799-802. 2006..Reoperation may be associated with significant morbidity and mortality. We report successful percutaneous transcatheter closure of an anastomotic graft leak utilizing an occluder device...
Preventing subacute thrombosisGordon Pate
Interventional Cardiology and Cardiac Catheterization, St. Paul s Hospital, Vancouver, British Columbia, Canada
J Invasive Cardiol 14:369-70. 2002
Heyde's syndrome: a reviewGordon E Pate
Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
J Heart Valve Dis 13:701-12. 2004..In those patients deemed unfit for surgery in whom no bleeding point can be identified, recurrent blood transfusions may offer some symptomatic relief...
Hemodynamic parameters are prognostically important in cardiogenic shock but similar following early revascularization or initial medical stabilization: a report from the SHOCK TrialRaban V Jeger
Cardiovascular Clinical Research Center, New York University School of Medicine, New York, NY, USA
Chest 132:1794-803. 2007..In cardiogenic shock (CS), conclusive data on serial hemodynamic measurements for treatment guidance and prognosis are lacking...
Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registryRupert Fincke
New York Presbyterian Hospital-Weill Cornell Medical Center, New York, New York, USA
J Am Coll Cardiol 44:340-8. 2004..032). CONCLUSIONS: Cardiac power is the strongest independent hemodynamic correlate of in-hospital mortality in patients with cardiogenic shock. Increasing age and female gender are independently associated with lower cardiac power...
Extensive thrombus of distal anastomosis of saphenous vein graftJavier Martín de la Torre
Interventional Cardiology Department, San Carlos University Hospital, Plaza Cristo Rey s n planta 2N, 28040 Madrid, Spain
J Invasive Cardiol 16:198-200. 2004
Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trialTimothy A Sanborn
Evanston Northwestern Healthcare, Evanston, Illinois 60201, USA
J Am Coll Cardiol 42:1373-9. 2003....
Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent rVladimir Dzavik
Interventional Cardiology Program, University Health Network, and University of Toronto, Toronto, Ontario, Canada
Am Heart J 149:1128-34. 2005..We sought to determine the reason for this finding by examining the baseline characteristics and outcomes of the 2 treatment groups by age...
Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Harvey D White
Green Lane Cardiovascular Service, Auckland City Hospital, Auckland 1030, New Zealand
Circulation 112:1992-2001. 2005..The objective of this analysis was to compare the effects of PCI and CABG on 30-day and 1-year survival in the SHOCK trial...
Transcatheter valve in valve implants for failed prosthetic valvesJohn G Webb
Catheter Cardiovasc Interv 70:765-6. 2007
Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trialsGregg W Stone
Columbia University Medical Center, Cardiovascular Research Foundation, New York City, NY, USA
Am J Cardiol 100:1370-5. 2007....
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging studyVladimir Dzavik
University Health Network, Toronto General Hospital, 6 246, 200 Elizabeth Street, Toronto M5G 2C4, Ontario, Canada
Eur Heart J 28:1109-16. 2007..We assessed preliminary efficacy and safety of four doses of l-n-monomethyl-arginine (l-NMMA), a non-selective NOS inhibitor, in patients with AMI complicated by CS despite an open infarct-related artery...
Percutaneous valve procedures: an updateLaurens F Tops
Curr Probl Cardiol 33:417-57. 2008..In addition, an update on the ongoing trials in percutaneous valve procedures is presented. Finally, the role of imaging in performing percutaneous valve procedures will be discussed...
Adjunctive use of the Rinspiration system for fluidic thrombectomy during primary angioplasty: the Rinspiration international registryMarco De Carlo
Cardiothoracic and Vascular Department, University of Pisa, Pisa, Italy
Catheter Cardiovasc Interv 72:196-203. 2008..The aim of this study was to investigate the safety and efficacy of an innovative thrombectomy device, the Rinspiration System, which simultaneously "rinses" the vessel with turbulent flow and aspirates thrombus...
Beating-heart percutaneous mitral valve repair using a transcatheter endovascular suturing device in an animal modelTasneem Z Naqvi
Edwards Lifesciences, 1 Edwards Way, Irvine, CA 92614, USA
Catheter Cardiovasc Interv 69:525-31. 2007..Because of its simplicity, it has been applied in minimally invasive surgery, and recently, in the design of endovascular closed-heart devices...
The Canadian Association of Interventional Cardiology and the Canadian Cardiovascular Society joint statement on drug-eluting stentsMachael P Love
Division of Cardiology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia
Can J Cardiol 23:121-3. 2007..The purpose of the present statement is to summarize the available evidence relating to DES thrombosis and to provide practical recommendations regarding DES use and antiplatelet therapy...
Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarctionJudith S Hochman
Cardiovascular Clinical Research Center, New York University School of Medicine, New York 10016, USA
JAMA 295:2511-5. 2006....
An early revascularization strategy is associated with a survival benefit for diabetic patients in cardiogenic shock after acute myocardial infarctionMichael E Farkouh
Cardiovascular Institute, Mount Sinai School of Medicine, Mount Sinai Medical Center, New York, New York 10029, USA
Clin Cardiol 29:204-10. 2006..The role of diabetes mellitus (DM) in cardiogenic shock (CS) complicating an acute myocardial infarction (AMI) is not well understood. Previous studies have reported an in-hospital mortality rate for patients with DM and CS of about 60%...
Stenting for coronary artery spasmShailesh Khatri
John Flynn Hospital, Gold Coast, Queensland, Australia
Catheter Cardiovasc Interv 56:16-20. 2002..In the rare, carefully selected patient, stents may represent an adjunct in the management of focal coronary artery spasm, although currently medical therapy remains the standard initial approach...
Restrictive physiology in cardiogenic shock: observations from echocardiographyHarmony R Reynolds
Department of Medicine, New York University School of Medicine, New York, NY, USA
Am Heart J 151:890.e9-15. 2006..We hypothesized that restrictive physiology plays a role in cardiogenic shock (CS)...
